Distribution of outpatient anticoagulant use and DOAC use according to income of country in which institutions were based
| Characteristic . | HICs (n = 59) . | LMICs (n = 26) . | P value∗ . |
|---|---|---|---|
| Outpatient anticoagulant use (median proportion, Q1-Q3) | |||
| DOACs | 45 (25-64) | 18 (5-53) | .02 for the interaction (see supplemental Appendix 2) |
| LMWH | 30 (15-47) | 47 (15-70) | |
| VKAs | 10 (10-25) | 15 (6-30) | |
| Percentage started on DOACs, n (%) | |||
| 0-10 | 34 (58) | 19 (73) | .47 |
| 11 to <25 | 9 (15) | 2 (8) | |
| 25 to <50 | 11 (19) | 2 (8) | |
| 50 to <75 | 2 (3) | 2 (8) | |
| ≥75 | 3 (5) | 1 (3) | |
| Percentage on long-term VKA/LMWH switched to DOACs, n (%)† | |||
| 0-10 | 14 (24) | 11 (44) | .20 |
| 11 to <25 | 13 (22) | 2 (8) | |
| 25 to <50 | 8 (13) | 5 (20) | |
| 50 to <75 | 14 (24) | 3 (12) | |
| ≥75 | 10 (17) | 4 (16) |
| Characteristic . | HICs (n = 59) . | LMICs (n = 26) . | P value∗ . |
|---|---|---|---|
| Outpatient anticoagulant use (median proportion, Q1-Q3) | |||
| DOACs | 45 (25-64) | 18 (5-53) | .02 for the interaction (see supplemental Appendix 2) |
| LMWH | 30 (15-47) | 47 (15-70) | |
| VKAs | 10 (10-25) | 15 (6-30) | |
| Percentage started on DOACs, n (%) | |||
| 0-10 | 34 (58) | 19 (73) | .47 |
| 11 to <25 | 9 (15) | 2 (8) | |
| 25 to <50 | 11 (19) | 2 (8) | |
| 50 to <75 | 2 (3) | 2 (8) | |
| ≥75 | 3 (5) | 1 (3) | |
| Percentage on long-term VKA/LMWH switched to DOACs, n (%)† | |||
| 0-10 | 14 (24) | 11 (44) | .20 |
| 11 to <25 | 13 (22) | 2 (8) | |
| 25 to <50 | 8 (13) | 5 (20) | |
| 50 to <75 | 14 (24) | 3 (12) | |
| ≥75 | 10 (17) | 4 (16) |